Fitness Trends Custom Recombinant Protein Production Services Mar

Custom Recombinant Protein Production Services
Market Outlook, and Opportunity Analysis 2018-
2026
Custom recombinant protein production plays a major role in advanced healthcare and is the
most efficient technique used in life sciences. Recombinant proteins are used in a wide range of
applications in research, biotechnology, and medicine.
The global custom recombinant protein production services market size was valued at US$
2,600.21 million in 2017, and is expected to exhibit a CAGR of 11.2% over the forecast period
(2018 – 2026).
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2737
Increasing funding in the field of life sciences is expected to propel growth of the custom
recombinant protein production services market
Recombinant protein is a manipulated form of protein, which is encoded by genes. It is used in
production of large quantities of protein, which is further used for manufacturing of therapeutic
commercial products. Increasing government initiatives and funding in the field of life sciences
is expected to boost growth of the market. For instance, Life Sciences Greenhouse of Central
Pennsylvania offers early stage funding of up to US$ 1-2 million in the form of convertible debt
or equity financing to viable life sciences companies, which have significant potential for
commercial growth.
Moreover, advancements in bioreactor systems have facilitated production of recombinant
protein within shorter time span, which in turn is expected to propel growth of the custom
recombinant protein production services market over the forecast period. For instance, according
to National Centre for Biotechnology Information (NCBI), in 2014, around 65.6% of clinical
scale manufacturers and 42% of commercial manufacturers adopted single-use bioreactors for
improvement in their bioprocessing.